273 related articles for article (PubMed ID: 31182419)
1. Anticholinergic burden and risk of cognitive impairment in elderly nursing home residents with depression.
Chatterjee S; Bali V; Carnahan RM; Chen H; Johnson ML; Aparasu RR
Res Social Adm Pharm; 2020 Mar; 16(3):329-335. PubMed ID: 31182419
[TBL] [Abstract][Full Text] [Related]
2. Risk of Mortality Associated with Anticholinergic Use in Elderly Nursing Home Residents with Depression.
Chatterjee S; Bali V; Carnahan RM; Chen H; Johnson ML; Aparasu RR
Drugs Aging; 2017 Sep; 34(9):691-700. PubMed ID: 28656508
[TBL] [Abstract][Full Text] [Related]
3. Anticholinergic Medication Use and Risk of Dementia Among Elderly Nursing Home Residents with Depression.
Chatterjee S; Bali V; Carnahan RM; Johnson ML; Chen H; Aparasu RR
Am J Geriatr Psychiatry; 2016 Jun; 24(6):485-95. PubMed ID: 26976294
[TBL] [Abstract][Full Text] [Related]
4. Anticholinergic Medication Use and Risk of Fracture in Elderly Adults with Depression.
Chatterjee S; Bali V; Carnahan RM; Chen H; Johnson ML; Aparasu RR
J Am Geriatr Soc; 2016 Jul; 64(7):1492-7. PubMed ID: 27294403
[TBL] [Abstract][Full Text] [Related]
5. Anticholinergic Prescribing in Medicare Part D Beneficiaries Residing in Nursing Homes: Results from a Retrospective Cross-Sectional Analysis of Medicare Data.
Niznik J; Zhao X; Jiang T; Hanlon JT; Aspinall SL; Thorpe J; Thorpe C
Drugs Aging; 2017 Dec; 34(12):925-939. PubMed ID: 29214512
[TBL] [Abstract][Full Text] [Related]
6. Anticholinergic Burden and Cognitive Impairment in Nursing Homes: A Comparison of Four Anticholinergic Scales.
Novella A; Elli C; Ianes A; Pasina L
Drugs Aging; 2023 Nov; 40(11):1017-1026. PubMed ID: 37620654
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and predictors of anticholinergic medication use in elderly nursing home residents with dementia: analysis of data from the 2004 National Nursing Home Survey.
Chatterjee S; Mehta S; Sherer JT; Aparasu RR
Drugs Aging; 2010 Dec; 27(12):987-97. PubMed ID: 21087068
[TBL] [Abstract][Full Text] [Related]
8. Anticholinergic Medication Use and Risk of Pneumonia in Elderly Adults: A Nested Case-Control Study.
Chatterjee S; Carnahan RM; Chen H; Holmes HM; Johnson ML; Aparasu RR
J Am Geriatr Soc; 2016 Feb; 64(2):394-400. PubMed ID: 26889844
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and Factors Associated with Cumulative Anticholinergic Burden Among Older Long-Stay Nursing Home Residents with Overactive Bladder.
Chatterjee S; Walker D; Kimura T; Aparasu RR
Drugs Aging; 2021 Apr; 38(4):311-326. PubMed ID: 33682017
[TBL] [Abstract][Full Text] [Related]
10. Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia.
Taylor-Rowan M; Kraia O; Kolliopoulou C; Noel-Storr AH; Alharthi AA; Cross AJ; Stewart C; Myint PK; McCleery J; Quinn TJ
Cochrane Database Syst Rev; 2022 Aug; 8(8):CD015196. PubMed ID: 35994403
[TBL] [Abstract][Full Text] [Related]
11. Anticholinergics Influence Transition from Normal Cognition to Mild Cognitive Impairment in Older Adults in Primary Care.
Campbell NL; Lane KA; Gao S; Boustani MA; Unverzagt F
Pharmacotherapy; 2018 May; 38(5):511-519. PubMed ID: 29600808
[TBL] [Abstract][Full Text] [Related]
12. Association between using medications with anticholinergic properties and short-term cognitive decline among older men: A retrospective cohort study in Taiwan.
Wu YH; Wang CJ; Hung CH; Chen LY; Lin MH; Wang PN; Chen LK
Geriatr Gerontol Int; 2017 Apr; 17 Suppl 1():57-64. PubMed ID: 28436193
[TBL] [Abstract][Full Text] [Related]
13. Depression symptoms and cognitive impairment in older nursing home residents in the USA: A latent class analysis.
Yuan Y; Min HS; Lapane KL; Rothschild AJ; Ulbricht CM
Int J Geriatr Psychiatry; 2020 Jul; 35(7):769-778. PubMed ID: 32250496
[TBL] [Abstract][Full Text] [Related]
14. Anticholinergic drug use and negative outcomes among the frail elderly population living in a nursing home.
Landi F; Dell'Aquila G; Collamati A; Martone AM; Zuliani G; Gasperini B; Eusebi P; Lattanzio F; Cherubini A
J Am Med Dir Assoc; 2014; 15(11):825-9. PubMed ID: 25282629
[TBL] [Abstract][Full Text] [Related]
15. Anticholinergic medications in patients admitted with cognitive impairment or falls (AMiCI). The impact of hospital admission on anticholinergic cognitive medication burden. Results of a multicentre observational study.
Weichert I; Romero-Ortuno R; Tolonen J; Soe T; Lebus C; Choudhury S; Nadarajah CV; Nanayakkara P; Orrù M; Di Somma S;
J Clin Pharm Ther; 2018 Oct; 43(5):682-694. PubMed ID: 29729025
[TBL] [Abstract][Full Text] [Related]
16. Association of anticholinergic drug exposure with the risk of dementia among older adults in Japan: The LIFE Study.
Okita Y; Kitamura T; Komukai S; Zha L; Komatsu M; Narii N; Murata F; Megumi M; Gon Y; Kimura Y; Kiyohara K; Sobue T; Fukuda H
Int J Geriatr Psychiatry; 2023 Dec; 38(12):e6029. PubMed ID: 38041399
[TBL] [Abstract][Full Text] [Related]
17. Association of Infection-Related Hospitalization With Cognitive Impairment Among Nursing Home Residents.
Gracner T; Agarwal M; Murali KP; Stone PW; Larson EL; Furuya EY; Harrison JM; Dick AW
JAMA Netw Open; 2021 Apr; 4(4):e217528. PubMed ID: 33890988
[TBL] [Abstract][Full Text] [Related]
18. Association of Anticholinergic Burden with Cognitive Impairment and Health Care Utilization Among a Diverse Ambulatory Older Adult Population.
Campbell NL; Perkins AJ; Bradt P; Perk S; Wielage RC; Boustani MA; Ng DB
Pharmacotherapy; 2016 Nov; 36(11):1123-1131. PubMed ID: 27711982
[TBL] [Abstract][Full Text] [Related]
19. Higher anticholinergic drug scale (ADS) scores are associated with peripheral but not cognitive markers of cholinergic blockade. Cross sectional data from 21 Norwegian nursing homes.
Kersten H; Molden E; Willumsen T; Engedal K; Bruun Wyller T
Br J Clin Pharmacol; 2013 Mar; 75(3):842-9. PubMed ID: 22924454
[TBL] [Abstract][Full Text] [Related]
20. Association between anticholinergic (atropinic) drug exposure and cognitive function in longitudinal studies among individuals over 50 years old: a systematic review.
Andre L; Gallini A; Montastruc F; Montastruc JL; Piau A; Lapeyre-Mestre M; Gardette V
Eur J Clin Pharmacol; 2019 Dec; 75(12):1631-1644. PubMed ID: 31468067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]